ClearPoint Neuro, Inc. (CLPT) Stock

ClearPoint Neuro, Inc. is a leading medical device company based in Solana Beach, California, primarily operating in the United States. Specializing in advanced technologies, the company focuses on developing and commercializing platforms that enable minimally invasive surgical procedures within the brain, guided by direct intra-procedural magnetic resonance imaging (MRI) guidance.

The cornerstone of ClearPoint Neuro's offerings is the ClearPoint system, designed for precise insertion of deep brain stimulation electrodes, biopsy needles, and the infusion of pharmaceuticals and laser catheters directly into the brain. Additionally, the company provides the ClearPoint Neuro Navigation System, integrated within MRI suites to enhance surgical accuracy and procedural outcomes.

ClearPoint Neuro, Inc. has cultivated a robust network of strategic partnerships and collaborations. These include agreements with industry leaders such as Boston Scientific Corporation, Koninklijke Philips N.V., and Blackrock Neurotech, along with renowned institutions like The Johns Hopkins University and University of California, San Francisco. These collaborations underscore ClearPoint Neuro's commitment to advancing neurosurgical innovation and enhancing patient carre through cutting-edge technology.

Founded in 1998 as MRI Interventions, Inc., the company rebranded as ClearPoint Neuro, Inc. in February 2020 to better reflect its specialized focus and evolving portfolio in neurological interventions. With a steadfast dedication to advancing MRI-guided neurosurgery, ClearPoint Neuro continues to drive innovation in the field, aiming to improve treatment options and outcomes for patients worldwide.